Lynch Regenerative Medicine, LLC completed a Series A financing led by Champion VC and Dr. Samuel Lynch to develop and commercialize innovative skin rejuvenation and regeneration solutions.

Jul 17, 2024•over 1 year ago

Amount Raised

$10 Million

Round Type

series a

FranklinBiotechnologyHealth Care

Investors

Dr. Samuel LynchChampion Vc

Description

Lynch Regenerative Medicine, LLC has completed its Series A financing to develop and commercialize innovative skin rejuvenation and regeneration solutions based on the only tissue growth factor that has been approved by the FDA and other international regulator bodies to be safe and effective in human tissue regeneration and wound healing.

Company Information

Company

Lynch Regenerative Medicine

Location

393 NICHOL MILL LANE

Franklin, Tennessee, United States

About

Lynch Regenerative Medicine, LLC., is pioneering innovative treatments that aim to revolutionize the $100 billion aesthetics and wound-care markets. Our mission is to leverage our regenerative medicine heritage, and our decades-long commitment to safe and effective regenerative products of the highest quality, to deliver exceptional results for our customers and their patients and thereby redefine the future of aesthetic regenerative medicine. The company was founded in 2023 by Dr. Lynch and is based in Franklin, Tennessee.

Related People

4 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends